Diagnosis and early detection of COPD using spirometry

Journal of Thoracic Disease

Volumn 6, Issue 11, 2014, Pages 1557-1569

  Johns, David P ^a   Walters, Julia A E ^a   Haydn Walters, E ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Case finding; chronic obstructive pulmonary disease (COPD); Flow volume curve; Spirometry

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY DIAGNOSIS; FORCED EXPIRATORY RATIO; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; PATHOGENESIS; PRACTICE GUIDELINE; PREVALENCE; PROCESS DEVELOPMENT; RESPIRATORY TRACT PARAMETERS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING CESSATION; SPIROMETER; SPIROMETRY; SYMPTOM;

EID: 84917697948     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2014.08.18     Document Type: Review

References (93)

1. Anderson DO, Ferris BG. Role of Tobacco Smoking in the Causation of Chronic Respiratory Disease. N Engl J Med 1962;267:787-94. [PubMed]
2. Reid L. Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis. Thorax 1960;15:132-41. [PubMed]
3. Thurlbeck WM, Angus GE. A distribution curve for chronic bronchitis. Thorax 1964;19:436-42. [PubMed]
4. Dunnill MS. The classification and quantification of emphysema. Proceedings of the Royal Society of Medicine 1969;62:1024-7. [PubMed]
5. Flotte TR, Mueller C. Gene therapy for alpha-1 antitrypsin deficiency. Hum Mol Genet 2011;20:R87-92. [PubMed]
6. Macklem PT. The physiology of small airways. Am J Respir Crit Care Med 1998;157:S181-3. [PubMed]
7. Macklem PT. A Century of the Mechanics of Breathing. Am J Respir Crit Care Med 2004;170:10-5. [PubMed]
8. Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J 2010;35:676-80. [PubMed]
9. Despas PJ, Leroux M, Macklem PT. Site of airway obstruction in asthma as determined by measuring maximal expiratory flow breathing air and a helium-oxygen mixture. J Clin Invest 1972;51:3235-43. [PubMed]
10. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;278:1355-60. [PubMed]
11. Martin RR, Lindsay D, Despas P, et al. The early detection of airway obstruction. Am Rev Respir Dis 1975;111:119-25. [PubMed]
12. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978;298:1277-81. [PubMed]
13. Macklem PT, Thurlbeck WM, Fraser RG. Chronic Obstructive Disease of Small Airways. Ann Intern Med 1971;74:167-77. [PubMed]
14. McDonough JE, Yuan R, Suzuki M, et al. Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease. N Engl J Med 2011;365:1567-75. [PubMed]
15. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD 2013. Available online: http://www.goldcopd.org/
16. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50. [PubMed]
17. Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust 2013;198:144-8. [PubMed]
18. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182:693-718. [PubMed]
19. Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003;97:115-22. [PubMed]
20. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733-43. [PubMed]
21. Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013;187:42-8. [PubMed]
22. Tager IB, Segal MR, Speizer FE, et al. The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. Am Rev Respir Dis 1988;138:837-49. [PubMed]
23. Sherman CB, Xu X, Speizer FE, et al. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992;146:855-9. [PubMed]
24. Kerstjens HA, Rijcken B, Schouten JP, et al. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax 1997;52:820-7. [PubMed]
25. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric Reference Values from a Sample of the General U.S. Population. Am J Respir Crit Care Med 1999;159:179-87. [PubMed]
26. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:446-51. [PubMed]
27. Fragoso CA, Concato J, McAvay G, et al. Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores. J Am Geriatr Soc 2011;59:1847-54. [PubMed]
28. Schermer TR, Quanjer PH. COPD screening in primary care: who is sick? Prim Care Respir J 2007;16:49-53. [PubMed]
29. Olive JT Jr, Hyatt RE. Maximal expiratory flow and total respiratory resistance during induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis 1972;106:366-76. [PubMed]
30. Hyatt RE, Scanlon PD, Nakamura M. Interpretation of pulmonary function tests: a practical guide. Philadelphia: Lippincott-Raven, 1997:23-4.
31. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9. [PubMed]
32. Peña VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-9. [PubMed]
33. Lindberg A, Bjerg A, Rönmark E, et al. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006;100:264-72. [PubMed]
34. van den Boom G, van Schayck CP, van Mollen MP, et al. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med 1998;158:1730-8. [PubMed]
35. Walters JA, Walters EH, Nelson M, et al. Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J 2011;20:396-402. [PubMed]
36. Zwar NA, Marks GB, Hermiz O, et al. Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. Med J Aust 2011;195:168-71. [PubMed]
37. Zieliñski J, Bednarek M; Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001;119:731-6. [PubMed]
38. U. S. Preventive Services Task Force. Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008;148:529-34. [PubMed]
39. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. Available online: http://guidance.nice.org.uk/CG101/Guidance/pdf/English
40. Jordan RE, Lam KB, Cheng KK, et al. Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach. Thorax 2010;65:492-8. [PubMed]
41. Van Schayck CP, Loozen JM, Wagena E, et al. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002;324:1370. [PubMed]
42. Haroon S, Adab P, Griffin C, et al. Case finding for chronic obstructive pulmonary disease in primary care: a pilot randomised controlled trial. Br J Gen Pract 2013;63:e55-62. [PubMed]
43. Levy ML, Fletcher M, Price DB, et al. International Primary Care Respiratory Group (IPCRG) Guidelines: Diagnosis of respiratory diseases in primary care. Prim Care Respir J 2006;15:20-34. [PubMed]
44. Price D, Crockett A, Arne M, et al. Spirometry in primary care case-identification, diagnosis and management of COPD. Prim Care Respir J 2009;18:216-23. [PubMed]
45. Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ 2010;182:673-8. [PubMed]
46. Vandevoorde J, Verbanck S, Gijssels L, et al. Early detection of COPD: a case finding study in general practice. Respir Med 2007;101:525-30. [PubMed]
47. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration 2006;73:285-95. [PubMed]
48. Price DB, Tinkelman DG, Nordyke RJ, et al. Scoring system and clinical application of COPD diagnostic questionnaires. Chest 2006;129:1531-9. [PubMed]
49. Sichletidis L, Spyratos D, Papaioannou M, et al. A combination of the IPAG questionnaire and PiKo-6æ flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J 2011;20:184-9. [PubMed]
50. Frith P, Crockett A, Beilby J, et al. Simplified COPD screening: validation of the PiKo-6 in primary care. Prim Care Respir J 2011;20:190-8. [PubMed]
51. Parkes G. Asymptomatic COPD and NICE guidelines. Br J Gen Pract 2011;61:294-5. [PubMed]
52. Gruffydd-Jones K, Loveridge C. The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines? Prim Care Respir J 2011;20:199-204. [PubMed]
53. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122. [PubMed]
54. Albers M, Schermer T, Molema J, et al. Do family physicians' records fit guideline diagnosed COPD? Fam Pract 2009;26:81-7. [PubMed]
55. Hansen EC, Walters J, Baker RW. Explaining chronic obstructive pulmonary disease (COPD): perceptions of the role played by smoking. Sociol Health Illn 2007;29:730-49. [PubMed]
56. Walters JA, Hansen E, Mudge P, et al. Barriers to the use of spirometry in general practice. Aust Fam Physician 2005;34:201-3. [PubMed]
57. Walters JA, Hansen E, Walters EH, et al. Under-diagnosis of Chronic obstructive Pulmonary Disease: a qualitative study in primary care. Respir Med 2008;102:738-43. [PubMed]
58. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8. [PubMed]
59. Wilt TJ, Niewoehner D, Kane RL, et al. Spirometry as a motivational tool to improve smoking cessation rates: A systematic review of the literature. Nicotine and Tobacco Research 2007;9:21-32. [PubMed]
60. Parkes G, Greenhalgh T, Griffin M, et al. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008;336:598-600. [PubMed]
61. Mannino DM, Aguayo SM, Petty TL, et al. Low lung function and incident lung cancer in the united states: Data from the first national health and nutrition examination survey follow-up. Arch Intern Med 2003;163:1475-80. [PubMed]
62. Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009;34:380-6. [PubMed]
63. Strachan DP. Ventilatory function, height, and mortality among lifelong non-smokers. J Epidemiol Community Health 1992;46:66-70. [PubMed]
64. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952-9. [PubMed]
65. Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011;66:49-54. [PubMed]
66. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009;374:721-32. [PubMed]
67. The COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease V2.30. 2011. Available online: www.copdx.org.au
68. Enright PL, Beck KC, Sherrill DL. Repeatability of Spirometry in 18,000 Adult Patients. Am J Respir Crit Care Med 2004;169:235-8. [PubMed]
69. Yawn BP, Enright PL, Lemanske RF Jr, et al. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest 2007;132:1162-8. [PubMed]
70. Hutchinson J. On the capacity of the lungs, and on the respiratory functions, with a view of establishing a precise and easy method of detecting disease by the spirometer. Med Chir Trans 1846;29:137-252. [PubMed]
71. Tiffeneau R, Pinelli A. Air circulant et air captive dans l'exploration de la fonction ventilatrice pulmonaire. Paris Med 1947;37:624-28. [PubMed]
72. Mead J, Turner J, Macklem P, et al. Significance of the relationship between lung elastic recoil and maximum expiratory flows. J Appl Physiol 1967;22:95-108. [PubMed]
73. Fry DL, Hyatt RE. Pulmonary mechanics. A unified analysis of the relationship between pressure, volume and gasflow in the lungs of normal and diseased human subjects. Am J Med 1960;29:672-89. [PubMed]
74. Buffels J, Degryse J, Heyrman J, et al. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest 2004;125:1394-9. [PubMed]
75. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS task force: Standardisation of spirometry. Eur Respir J 2005;26:319-38. [PubMed]
76. Johns DP, Burton D, Walters JA, et al. National survey of spirometer ownership and usage in general practice in Australia. Respirology 2006;11:292-8. [PubMed]
77. Enright P, Schermer T. Don't pay for poor quality spirometry tests. Prim Care Respir J 2013;22:15-6. [PubMed]
78. Eaton T, Withy S, Garrett JE, et al. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999;116:416-23. [PubMed]
79. Tuomisto L, Jarvinen V, Laitinen J, et al. Asthma Programme in Finland: the quality of primary care spirometry is good. Prim Care Respir J 2008;17:226-31. [PubMed]
80. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000;117:1146-61. [PubMed]
81. Walters JA, Hansen E, Johns D, et al. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of Chronic Obstructive Pulmonary Disease. Thorax 2008;63:408-14. [PubMed]
82. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68. [PubMed]
83. Mead J. Analysis of the configuration of maximum expiratory flow-volume curves. J Appl Physiol Respir Environ Exerc Physiol 1978;44:156-65. [PubMed]
84. Ohwada A, Takahashi K. Concave pattern of a maximal expiratory flow-volume curve: a sign of airflow limitation in adult bronchial asthma. Pulm Med 2012;2012:797495.
85. Dosman J, Bode F, Urbanetti J, et al. The Use of a Helium-Oxygen Mixture during Maximum Expiratory Flow to Demonstrate Obstruction in Small Airways in Smokers. J Clin Invest 1975;55:1090-9. [PubMed]
86. Dawson SV, Elliott EA. Wave-speed limitation on expiratory flow-a unifying concept. J Appl Physiol Respir Environ Exerc Physiol 1977;43:498-515. [PubMed]
87. Schachter EN, Kapp MC, Maunder LR, et al. Smoking and cotton dust effects in cotton textile workers: an analysis of the shape of the maximum expiratory flow volume curve. Environmental health perspectives 1986;66:145-8. [PubMed]
88. Kapp MC, Schachter EN, Beck GJ, et al. The shape of the maximum expiratory flow volume curve. Chest 1988;94:799-806. [PubMed]
89. Kraan J, van der Mark TW, Koeter GH. Changes in maximum expiratory flow-volume curve configuration after treatment with inhaled corticosteroids. Thorax 1989;44:1015-21. [PubMed]
90. Omland O, Sigsgaard T, Pedersen OF, et al. The shape of the maximum expiratory flow-volume curve reflects exposure in farming. Ann Agric Environ Med 2000;7:71-8. [PubMed]
91. Nève V, Matran R, Baquet G, et al. Quantification of shape of flow-volume loop of healthy preschool children and preschool children with wheezing disorders. Pediatr Pulmonol 2012;47:884-94. [PubMed]
92. Wildhaber JH, Sznitman J, Harpes P, et al. Correlation of spirometry and symptom scores in childhood asthma and the usefulness of curvature assessment in expiratory flow-volume curves. Respir Care 2007;52:1744-52. [PubMed]
93. Zheng CJ, Adams AB, McGrail MP, et al. A proposed curvilinearity index for quantifying airflow obstruction. Respir Care 2006;51:40-5. [PubMed